Facilities

Facilities

Advanced Manufacturing Capabilities and Global Compliance

Combining its expertise, capabilities and long term experience of multi-step synthesis and fractionations at high temperatures has provided Aarti Drugs Ltd. with an excellent position as a manufacturing partner. The capacity of these multi-purpose plant ranges from 1 up till 100’s of tons.

With (a strength of) eight manufacturing locations in its portfolio , Aarti Drugs Ltd. today, has total reaction capacity in excess of 1300 KL, consisting of SS and GL reactors across its units, varying from 0.5 KL – 18 KL. Manufacturing in accordance with GMP regulations norms, Pilot Plants, Process development labs, In – Process QC labs and dedicated product processing areas are common features across every plant.

USFDA - Compliant Facility

  • The Company has established robust unit processes for milling, sieving, blending, micronising, and packing. These facilities have been inspected and approved by top global clients.
  • To enter the US generics market, a USFDA-compliant, multipurpose manufacturing facility has been commissioned and is fully operational.
  • The Company’s manufacturing strength lies in continuous process improvement, strict safety standards, and consistent product quality.

Manufacturing Footprint in India